Semaglutide and Other GLP-1 Agonists: A Boon for the Arthroplasty Industry
Stopping treatment leads to gradual return to baseline hair density within ~ 8 weeks
GLP-1 RA therapy is associated with a low risk of hypoglycaemia [15,16,17,18,19,20,21,22,23,24,25,26,27,28], which means that in the UK, routine declaration to the Driver and Vehicle Licensing Agency (DVLA) is not required unless there is history of hypoglycaemia or significant eye-related or circulatory problems [94]
Against those benchmarks, oral agents currently sit at a level of efficacy that is meaningful but measurably lower
Unlike direct hGH injections, sermorelin encourages your body to produce its own growth hormone, leading to more balanced and sustainable results
Related: Read our follow-up on the NPR report on peptide restrictions and what it means for patients